Literature DB >> 29296458

Summary of the lecture given on June 1, 2017 on the occasion of the Jacob I. Fabrikant Award ceremony.

Ben J Slotman1.   

Abstract

Year:  2017        PMID： 29296458      PMCID： PMC5675504     

Source DB:  PubMed          Journal:  J Radiosurg SBRT


× No keyword cloud information.
  8 in total

1.  Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis.

Authors:  David Palma; Otto Visser; Frank J Lagerwaard; Jose Belderbos; Ben J Slotman; Suresh Senan
Journal:  J Clin Oncol       Date:  2010-11-01       Impact factor: 44.544

2.  Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.

Authors:  Sashendra Senthi; Frank J Lagerwaard; Cornelis J A Haasbeek; Ben J Slotman; Suresh Senan
Journal:  Lancet Oncol       Date:  2012-06-22       Impact factor: 41.316

3.  Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Authors:  Frank J Lagerwaard; Naomi E Verstegen; Cornelis J A Haasbeek; Ben J Slotman; Marinus A Paul; Egbert F Smit; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-19       Impact factor: 7.038

4.  Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands.

Authors:  C J A Haasbeek; D Palma; O Visser; F J Lagerwaard; B Slotman; S Senan
Journal:  Ann Oncol       Date:  2012-05-02       Impact factor: 32.976

5.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

6.  Stereotactic heavy-ion Bragg peak radiosurgery for intra-cranial vascular disorders: method for treatment of deep arteriovenous malformations.

Authors:  J I Fabrikant; J T Lyman; Y Hosobuchi
Journal:  Br J Radiol       Date:  1984-06       Impact factor: 3.039

Review 7.  Radiotherapy combination opportunities leveraging immunity for the next oncology practice.

Authors:  Fernanda G Herrera; Jean Bourhis; George Coukos
Journal:  CA Cancer J Clin       Date:  2016-08-29       Impact factor: 508.702

8.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer.

Authors:  Frank J Lagerwaard; Cornelis J A Haasbeek; Egbert F Smit; Ben J Slotman; S Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.